@kyleserikawa.bsky.social
Scientist. Genetics, genomics, biotech, systems. Interested in all kinds of things.
@jmaraganore.bsky.social
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer. CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@srikosuri.bsky.social
Cofounder/CEO Octant BoD Ginkgo Bioworks Defense Science Board for Emerging Biotech Fmr: Associate Professor, UCLA
@vishalgulati.bsky.social
Specialist computational biology and cognitive automation VC. Not a fan of mouse click economy. Founded @RecodeVentures #medsky #biosky #healthsky
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@natashaloder.bsky.social
Health Editor, The Economist. #Science #medicine #health, aspiring optimist, omnivorous information eater, mother of dragons. Free words at: Overmatter.substack.com
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@thedawnbell.bsky.social
Connector of dots and people. Founder AntliaBio and Myracle Tx. Passionate about science, innovation, and SEC football #GoGators.
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@mandyjacksonwrites.bsky.social
Managing Editor, US Commercial News, Scrip; pharma, biotech, finance, M&A, clinical trial results, strategy, drug pricing, etc.
@jeremymax.bsky.social
Lifelong commitment to patients, defeating disease through innovation. Fundamental belief in fighting for democracy. Driven by facts, hard data. Love the natural world. Inspired by those who speak out, show compassion, and who stand up for their beliefs.
@arsalan.endpoints.news
Founder/CEO of Endpoints News (acquired by the Financial Times). Lawrence, Kansas-based aviator. Sharing occasional biopharma news biz takes and cockpit views. @AKAarsalan on twitter
@biopharmamike.bsky.social
Life sciences & healthcare thought leader with 40+ years experience as journalist and analyst covering issues consequential to biopharma and Medtech stakeholders
@srinigrao.bsky.social
Co-CEO and Co-Founder of atai Life Sciences (www.atai.life). Opinions expressed are my own.
@hannahkuchler.bsky.social
Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK.
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@flobrand.bsky.social
Co-Founder of atai life sciences - NASDAQ:ATAI. Let’s bridge the gap between what the #mentalhealth system currently provides, and what people really need. Views are my own.
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app